The potential impact of COVID-19-related disruption on tuberculosis burden

C. Finn McQuaid, Nicky McCreesh, Jonathan M. Read, Tom Sumner, Rein M.G.J. Houben, Richard G. White, Rebecca C. Harris

Source: Eur Respir J, 56 (2) 2001718; 10.1183/13993003.01718-2020
Journal Issue: August
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Finn McQuaid, Nicky McCreesh, Jonathan M. Read, Tom Sumner, Rein M.G.J. Houben, Richard G. White, Rebecca C. Harris. The potential impact of COVID-19-related disruption on tuberculosis burden. Eur Respir J, 56 (2) 2001718; 10.1183/13993003.01718-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The influence of social and economic factors on incidence of tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 192s
Year: 2005

The impact of drug resistance on TB control and elimination
Source: International Congress 2014 – New diagnostics and better treatments for multidrug and extensively drug-resistant tuberculosis (M/XDR-TB)
Year: 2014



The effect, the consequences and associated factors of poverty on tuberculosis in Turkey
Source: Eur Respir J 2003; 22: Suppl. 45, 517s
Year: 2003

Rimfampicin importance in tuberculosis treatment
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008

Treatment outcome of MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008


The burden of childhood and adult tuberculosis, including MDR and TDR TB
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014

The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021


The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis
Source: Eur Respir J 2012; 39: 626-634
Year: 2012



Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China
Source: Eur Respir J, 56 (3) 2002710; 10.1183/13993003.02710-2020
Year: 2020



The cost of tuberculosis sequelae
Source: Eur Respir J 2014; 44: 824-825
Year: 2014


The cost of tuberculosis sequelae
Source: Eur Respir J 2014; 44: 822-824
Year: 2014


Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support
Source: Eur Respir J, 52 (5) 1801363; 10.1183/13993003.01363-2018
Year: 2018



Primary drug resistance against mycobacterium tuberculosis in a high burden country
Source: Eur Respir J 2006; 28: Suppl. 50, 587s
Year: 2006

Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


The impact of first symptoms on patient delay in pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 380s
Year: 2006

How does tobacco-smoking contribute to the tuberculosis burden?
Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news?
Year: 2007


Role of the family physician concerning the tuberculosis control in a high incidence rural-suburban milieu
Source: Eur Respir J 2002; 20: Suppl. 38, 163s
Year: 2002

Frequency of side effects among patients with drug resistant tuberculosis (DR-TB) by resistance pattern in a high burden country.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


The impact of revealing the diagnosis of TB on emotional level
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007


Key role of tuberculosis services funding mechanisms in tuberculosis control and elimination
Source: Eur Respir J 2015; 45: 289-291
Year: 2015